Is FKBP involved in the immunosuppressive and/or toxic mechanism of action of FK 506?
Sigal
N H
NH
Department of Immunology Research, Merck, Sharp & Dohme Research Laboratories, Rahway, NJ 07065.
Dumont
F J
FJ
Siekierka
J J
JJ
Wiederrecht
G
G
Parent
S A
SA
Brizuela
L
L
D000591:Amino Acid Isomerases / Q000235:genetics / Q000502:physiology; D000818:Animals; D002352:Carrier Proteins / Q000235:genetics / Q000502:physiology*; D002872:Chromosome Deletion; D016572:Cyclosporine / Q000494:pharmacology; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D009492:Neurospora crassa / Q000235:genetics; D019696:Peptidylprolyl Isomerase; D012441:Saccharomyces cerevisiae / Q000235:genetics; D016559:Tacrolimus / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D022021:Tacrolimus Binding Proteins
D002352:Carrier Proteins; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D000591:Amino Acid Isomerases; D022021:Tacrolimus Binding Proteins; D019696:Peptidylprolyl Isomerase; D016559:Tacrolimus